StockNews.com Initiates Coverage on Edap Tms (NASDAQ:EDAP)

Analysts at StockNews.com assumed coverage on shares of Edap Tms (NASDAQ:EDAP) in a research note issued to investors on Friday. The firm set a “hold” rating on the medical equipment provider’s stock.

Edap Tms Stock Performance

Shares of NASDAQ:EDAP opened at $2.44 on Friday. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.18 and a quick ratio of 1.46. Edap Tms has a 1 year low of $2.00 and a 1 year high of $8.50. The firm has a market capitalization of $90.52 million, a PE ratio of -3.75 and a beta of 0.36. The business’s 50 day moving average price is $2.27 and its 200-day moving average price is $2.98.

Edap Tms (NASDAQ:EDAP) last released its earnings results on Thursday, November 7th. The medical equipment provider reported ($0.19) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.16) by ($0.03). The business had revenue of $14.42 million for the quarter, compared to analysts’ expectations of $17.00 million. Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%. During the same period in the previous year, the company earned ($0.12) EPS. As a group, equities research analysts expect that Edap Tms will post -0.6 earnings per share for the current fiscal year.

Institutional Trading of Edap Tms

Institutional investors have recently made changes to their positions in the company. Parkman Healthcare Partners LLC acquired a new stake in Edap Tms during the third quarter worth $395,000. Orion Capital Management LLC increased its position in shares of Edap Tms by 10.4% during the 3rd quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock worth $178,000 after purchasing an additional 6,600 shares during the last quarter. BNP Paribas Financial Markets raised its holdings in Edap Tms by 23.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock valued at $59,000 after buying an additional 4,400 shares during the period. Finally, Redhawk Wealth Advisors Inc. acquired a new position in Edap Tms in the third quarter valued at about $36,000. Hedge funds and other institutional investors own 62.74% of the company’s stock.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.